US FDA granted 510(k) clearance to Axiostat Chitosan Hemostatic Dressing, which is cleared as an over-the-counter product to stop external bleeding. In the US, the product will be marketed by Advamedica Inc, headquartered in Boston.
Axiostat Hemostatic Dressing is a patented Chitosan biopolymer-based product which has prevented countless deaths due to bleeding in military battlefields, hospitals, and on roads worldwide. The innovative first-aid dressing stops uncontrollable bleeding within just two-three minutes of its application.
Axiostat has earlier received CE mark approval in the European Union. The award-winning product is being used in the frontline battlefield by many defence forces across the globe.